Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2024 | 3 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance.
Cancers (Basel). 2021 Jul 26;13(15):3757. doi: 10.3390/cancers13153757.
Cancers (Basel). 2021.
PMID: 34359657
Free PMC article.
Review.
Galectin-1, a novel promising target for outcome prediction and treatment in SCLC.
Corral JM, Puerto-Nevado LD, Cedeño M, Río-Vilariño A, Mahillo-Fernández I, Galeano C, Baños N, García-Foncillas J, Dómine M, Cebrián A.
Corral JM, et al. Among authors: rio vilarino a.
Biomed Pharmacother. 2022 Dec;156:113987. doi: 10.1016/j.biopha.2022.113987. Epub 2022 Nov 8.
Biomed Pharmacother. 2022.
PMID: 36411654
Free article.
Item in Clipboard
Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest.
Cenigaonandia-Campillo A, Garcia-Bautista A, Rio-Vilariño A, Cebrian A, Del Puerto L, Pellicer JA, Gabaldón JA, Pérez-Sánchez H, Carmena-Bargueño M, Meroño C, Traba J, Fernandez-Aceñero MJ, Baños-Herraiz N, Mozas-Vivar L, Núñez-Delicado E, Garcia-Foncillas J, Aguilera Ó.
Cenigaonandia-Campillo A, et al. Among authors: rio vilarino a.
Mol Oncol. 2024 Feb 29. doi: 10.1002/1878-0261.13616. Online ahead of print.
Mol Oncol. 2024.
PMID: 38425123
Free article.
Item in Clipboard
Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer.
Solanes-Casado S, Cebrián A, Rodríguez-Remírez M, Mahíllo I, García-García L, Río-Vilariño A, Baños N, de Cárcer G, Monfort-Vengut A, Castellano V, Fernández-Aceñero MJ, García-Foncillas J, Del Puerto-Nevado L.
Solanes-Casado S, et al. Among authors: rio vilarino a.
Biomed Pharmacother. 2021 Dec;144:112347. doi: 10.1016/j.biopha.2021.112347. Epub 2021 Oct 23.
Biomed Pharmacother. 2021.
PMID: 34700228
Free article.
Item in Clipboard
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A.
Rio-Vilariño A, et al.
Br J Cancer. 2024 May;130(8):1402-1413. doi: 10.1038/s41416-024-02649-z. Epub 2024 Mar 11.
Br J Cancer. 2024.
PMID: 38467828
Free PMC article.
Item in Clipboard
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A.
Rio-Vilariño A, et al.
Br J Cancer. 2024 May;130(8):1414. doi: 10.1038/s41416-024-02667-x.
Br J Cancer. 2024.
PMID: 38575733
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite